Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cardiovascular diseases 15

Cardiovascular Diseases

MedTech News and Updates for GenScript, Biomerics, MedAlliance, Filterlex

Notizia - Recent Pharma, Healthcare and Biotech Happenings

GenScript Enters Distribution Agreement with EUROIMMUN; Biomerics’s New Facility in Galway (Ireland); MedAlliance’s SELUTION SLR DEB; OmniGuide’s RevoLix HTL Hybrid Thulium Laser; Filterlex’s CAPTIS Full-Body Embolic Protection Device; Orthofix’s M6-C Artificial Cervical Disc

GenScript USA Announced the Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neutralizing Antibody Detection Kit On May 26, 2022, GenScript USA Inc., a subsidiary of GenScript Biotech Corporation and a world-leading biotechnology company, agreed with EUROIMMUN US Inc., a PerkinElmer Company, for the distribution of the GenScript cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in the United States and Canada. The test kit is used to measure the relative concentration of neutralizing antibodies (NAbs) in patients recovering from COVID-19. The company announced that the test kit had already received the US FDA Emergency Use Authorization...

Explore More...

WORLD HEART DAY

WORLD HEART DAY | 29-09-2018

transthyretin amyloidosis

Notizia

transthyretin amyloidosis

Notizia

astellas

Commercial

cancer

Key Clinical Outcomes- 30/07/2018

Default Blog Image

NF-κB Inhibitors- A Promising Future

SANOFI

Cholesterol drug Praluent successful in reducing heart risk

Entasis

December 7 Business Cocktail

Chemists may help solve the air-pollution health crisis

Notizia

AstraZeneca and Incyte Collaborate; Tocagen’s therapy; FDA warns companies;FDA Revokes

Novo petitions FDA;J&J invests; Xarelto’s trial; Roche’s Tecentriq

Thrombolytic Sciences’ trial; NurOwn for ALS; Biosimilar receives approval; Trelegy Ellipta for the treatment of COPD

Cannabidiol trial; MyoKardia aims; LDL drug data

Personalized Medicine

Sanofi invests; ICER pitches; $6M in NIH; Pfizer, Roche cancer drug pricing

Lilly moves ahead; Authorities raid; Bristol-Myers, AZ in legal; PhRMA expected to weed out

Therapeutics

Merck’s Keytruda sales; Valeant on name change; Pfizer – BMS; Amgen puts Repatha outcomes for deal

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly